Try our beta test site
2 studies found for:    16267411 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
2 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution

Study has passed its completion date and status has not been verified in more than two years.